Netarsudil as an Add-On Therapy for Glaucoma Patients Who Are Already on Maximally Tolerated Topical Medical Therapy (Code-T0333) (2025). Medical Thesis. Available at: https://medicalthesis.org/index.php/mt/catalog/book/339 (Accessed: 7 June 2025).